CORC  > 山东大学
Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy
Lin, Ying-Li; Deng, Qiu-Kui; Wang, Yu-Hao; Fu, Xing-Li; Ma, Jian-Guo; Li, Wen-Ping
刊名MEDICAL SCIENCE MONITOR
2015
卷号21页码:3955-3960
关键词Biological Markers DNA Methylation Prostatic Neoplasms
DOI10.12659/MSM.896763
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4767077
专题山东大学
作者单位1.Jiangsu Univ, Dept Urol, Xuzhou Canc Hosp, Affiliated Xuzhou Hosp, Xuzhou, Jiangsu, Peoples R China.
2.Shandong Univ,
推荐引用方式
GB/T 7714
Lin, Ying-Li,Deng, Qiu-Kui,Wang, Yu-Hao,et al. Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy[J]. MEDICAL SCIENCE MONITOR,2015,21:3955-3960.
APA Lin, Ying-Li,Deng, Qiu-Kui,Wang, Yu-Hao,Fu, Xing-Li,Ma, Jian-Guo,&Li, Wen-Ping.(2015).Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy.MEDICAL SCIENCE MONITOR,21,3955-3960.
MLA Lin, Ying-Li,et al."Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy".MEDICAL SCIENCE MONITOR 21(2015):3955-3960.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace